BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 28665782)

  • 1. Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models.
    Patel SP; Bristol A; Saric O; Wang XP; Dubeykovskiy A; Arlen PM; Morse MA
    Cancer Immunol Immunother; 2013 Jun; 62(6):1011-9. PubMed ID: 23591984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocalyxin enhances the adherence of cells to platelets.
    Larrucea S; Butta N; Rodriguez RB; Alonso-Martin S; Arias-Salgado EG; Ayuso MS; Parrilla R
    Cell Mol Life Sci; 2007 Nov; 64(22):2965-74. PubMed ID: 17922228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cx
    Li G; Tanaka T; Ouchida T; Kaneko MK; Suzuki H; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2024 Apr; 43(2):59-66. PubMed ID: 38593439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservation of oncofetal antigens on human embryonic stem cells enables discovery of monoclonal antibodies against cancer.
    Tan HL; Yong C; Tan BZ; Fong WJ; Padmanabhan J; Chin A; Ding V; Lau A; Zheng L; Bi X; Yang Y; Choo A
    Sci Rep; 2018 Aug; 8(1):11608. PubMed ID: 30072783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical Analysis Using Antipodocalyxin Monoclonal Antibody PcMab-47 Demonstrates Podocalyxin Expression in Oral Squamous Cell Carcinomas.
    Itai S; Yamada S; Kaneko MK; Harada H; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Oct; 36(5):220-223. PubMed ID: 28873000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H
    Itai S; Fujii Y; Kaneko MK; Yamada S; Nakamura T; Yanaka M; Saidoh N; Chang YW; Handa S; Takahashi M; Suzuki H; Harada H; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Aug; 36(4):143-148. PubMed ID: 28700270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Array expression meta-analysis of cancer stem cell genes identifies upregulation of PODXL especially in DCC low expression meningiomas.
    Schulten HJ; Hussein D
    PLoS One; 2019; 14(5):e0215452. PubMed ID: 31083655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cancer-specific anti-podocalyxin monoclonal antibody (60-mG
    Kaneko MK; Ohishi T; Kawada M; Kato Y
    Biochem Biophys Rep; 2020 Dec; 24():100826. PubMed ID: 33088928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma.
    Itai S; Ohishi T; Kaneko MK; Yamada S; Abe S; Nakamura T; Yanaka M; Chang YW; Ohba SI; Nishioka Y; Kawada M; Harada H; Kato Y
    Oncotarget; 2018 Apr; 9(32):22480-22497. PubMed ID: 29854293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocalyxin in Normal Tissue and Epithelial Cancer.
    Le Tran N; Wang Y; Nie G
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34201212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipodocalyxin Antibody chPcMab-47 Exerts Antitumor Activity in Mouse Xenograft Models of Colorectal Adenocarcinomas.
    Kaneko MK; Kunita A; Yamada S; Nakamura T; Yanaka M; Saidoh N; Chang YW; Handa S; Ogasawara S; Ohishi T; Abe S; Itai S; Harada H; Kawada M; Nishioka Y; Fukayama M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Aug; 36(4):157-162. PubMed ID: 28665782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.
    Ogasawara S; Kaneko MK; Yamada S; Honma R; Nakamura T; Saidoh N; Yanaka M; Yoshida K; Fujii Y; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Apr; 36(2):50-56. PubMed ID: 28384052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts.
    Suzuki H; Ohishi T; Tanaka T; Kaneko MK; Kato Y
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203331
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.